胆囊收缩素B受体拮抗剂经阻断基底外侧杏仁核长时程增强治疗抑郁
该研究探讨应激相关抑郁样行为中基底外侧杏仁核(BLA)内胆囊收缩素(CCK)及CCKBR的作用。CCK-KO小鼠BLA的LTP受损,EC的CCK神经元投射至BLA并通过释放CCK促进应激易感性,CCKBR拮抗剂阻断BLA的LTP形成并在慢性社会挫败模型中显示抗抑郁样效应,提示CCKBR可能是抑郁治疗靶点。
要点
- CCK-KO小鼠BLA的长时程增强(LTP)受损。
- EC的CCK神经元投射至BLA,光遗传激活促进应激易感性。
- BLA内注射CCKBR拮抗剂在慢性社会挫败模型中显示抗抑郁样效应。
核心结论
- CCKBR可能是治疗抑郁的潜在靶点。
研究设计与样本
- 采用CCK敲除(CCK-KO)小鼠、CCKBR敲除(CCKBR-KO)小鼠及慢性社会挫败应激模型进行机制与干预研究。
主要发现
- CCK-KO小鼠BLA的LTP受损,低频刺激后应用CCK4可诱导LTP。
- EC的CCK神经元投射至BLA,光遗传激活该投射通过释放CCK促进应激易感性。
- EC的CCK神经元支配BLA内CCKBR细胞,CCKBR-KO小鼠BLA的LTP受损。
- CCKBR拮抗剂阻断高频刺激诱导的BLA的LTP形成。
- 向BLA灌注CCKBR拮抗剂在慢性社会挫败应激模型中显示抗抑郁样效应。
临床怎么用
- 提示CCKBR拮抗剂可能通过阻断BLA的LTP发挥抗抑郁作用,但尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Depression is a common and severe mental disorder. Evidence suggested a substantial causal relationship between stressful life events and the onset of episodes of major depression. However, the stress-induced pathogenesis of depression and the related neural circuitry is poorly understood. Here, we investigated how cholecystokinin (CCK) and CCKBR in the basolateral amygdala (BLA) are implicated in stress-mediated depressive-like behavior. The BLA mediates emotional memories, and long-term potentiation (LTP) is widely considered a trace of memory. We identified that the cholecystokinin knockout (CCK-KO) mice impaired LTP in the BLA, while the application of CCK4 induced LTP after low-frequency stimulation (LFS). The entorhinal cortex (EC) CCK neurons project to the BLA and optogenetic activation of EC CCK afferents to BLA-promoted stress susceptibility through the release of CCK. We demonstrated that EC CCK neurons innervate CCKBR cells in the BLA and CCK-B receptor knockout (CCKBR-KO) mice impaired LTP in the BLA. Moreover, the CCKBR antagonists also blocked high-frequency stimulation (HFS) induced LTP formation in the BLA. Notably, CCKBR antagonists infusion into the BLA displayed an antidepressant-like effect in the chronic social defeat stress model. Together, these results indicate that CCKBR could be a potential target to treat depression.
引用
- Zhang X, Asim M, Fang W, et al. Cholecystokinin B receptor antagonists for the treatment of depression via blocking long-term potentiation in the basolateral amygdala. Mol Psychiatry. 2023. PMID: 37365241. doi:10.1038/s41380-023-02127-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。